Header Logo

Connection

MICHAEL TAYLOR to Transforming Growth Factor beta

Back to Details
This is a "connection" page, showing publications MICHAEL TAYLOR has written about Transforming Growth Factor beta.
MICHAEL TAYLOR
Connection Strength
0.506
Transforming Growth Factor beta
  1. The AHR pathway represses TGF?-SMAD3 signalling and has a potent tumour suppressive role in SHH medulloblastoma. Sci Rep. 2020 01 10; 10(1):148.
    View in: PubMed
    Score: 0.132
  2. An autocrine ActivinB mechanism drives TGF?/Activin signaling in Group 3 medulloblastoma. EMBO Mol Med. 2019 08; 11(8):e9830.
    View in: PubMed
    Score: 0.127
  3. TGF-? Determines the Pro-migratory Potential of bFGF Signaling in Medulloblastoma. Cell Rep. 2018 06 26; 23(13):3798-3812.e8.
    View in: PubMed
    Score: 0.118
  4. Canonical TGF-? pathway activity is a predictor of SHH-driven medulloblastoma survival and delineates putative precursors in cerebellar development. Brain Pathol. 2013 Mar; 23(2):178-91.
    View in: PubMed
    Score: 0.080
  5. Metastatic group 3 medulloblastoma is driven by PRUNE1 targeting NME1-TGF-?-OTX2-SNAIL via PTEN inhibition. Brain. 2018 05 01; 141(5):1300-1319.
    View in: PubMed
    Score: 0.029
  6. Subgroup-specific structural variation across 1,000 medulloblastoma genomes. Nature. 2012 Aug 02; 488(7409):49-56.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.